Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

Glofitamab with GemOx for diffuse large B-cell lymphoma - Authors' reply. — SciRadar

Back to results

Lancet (London, England)

Glofitamab with GemOx for diffuse large B-cell lymphoma - Authors' reply.

Jeremy S Abramson, Matthew Ku, Gareth P Gregory, Christopher P Fox

Published: 202510.1016/S0140-6736(25)01583-1

No abstract available for this study.